Legislators
Bills
Statements
Lobbying
Travel
Searching...- Bills
- S.481
S.481: Improving Regulatory Transparency for New Medical Therapies Act
About This Bill
- This bill was introduced in the 114th Congress
- This bill is primarily about health
- Introduced Feb. 12, 2015
- Latest Major Action Oct. 1, 2015
Bill Sponsor
Bill Cosponsors
3 (2 Democrats, 1 Republican)
Bill Summary
Improving Regulatory Transparency for New Medical Therapies Act (Sec. 2) This bill amends the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act to delay the effective date of approval of a drug, biological product, or animal drug for which the Food and Drug Administration (FDA) recommends controls under the Controlled Substances Act until the Department of Justice (DOJ) issues a final interim rule for the drug. This delay...
(Source: Library of Congress)
What Lawmakers Are Saying About This Bill
Bill Actions
| Date | Description |
|---|---|
| Oct. 1, 2015 |
Placed on Senate Legislative Calendar under General Orders. Calendar No. 245.
|
| Oct. 1, 2015 |
Committee on Health, Education, Labor, and Pensions. Reported by Senator Alexander with an amendment in the nature of a substitute. Without written report.
|
| Sept. 30, 2015 |
Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.
|
| Feb. 12, 2015 |
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
|
| Feb. 12, 2015 |
Introduced in the Senate by Orrin G. Hatch (R-Utah) |